Quick Answer
Coya Therapeutics, Inc. reported Total Revenue of $7.95 million for fiscal year 2025.
Coya Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $7.95M | +123.6% |
| 2024 | $3.55M | -40.8% |
| 2023 | $6.00M | — |
| 2022 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.56M | — | +2078.4% |
| June 30, 2025 | $163.6K | -95.2% | -36.6% |
| March 31, 2025 | $257.9K | +103.3% | — |
| September 30, 2024 | $0.00 | — | -100.0% |
| June 30, 2024 | $3.43M | — | +2600.5% |
| March 31, 2024 | $126.8K | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- Coya Therapeutics, Inc. showed an increase of +123.6% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Coya Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: